Vasodilatory Actions of Glucagon-Like Peptide 1 Are Preserved in Skeletal and Cardiac Muscle Microvasculature but Not in Conduit Artery in Obese Humans With Vascular Insulin Resistance.
Nasui WangAlvin W K TanLinda A JahnLee HartlineJames T PatrieShaoda LinEugene J BarrettKevin W AylorZhenqi LiuPublished in: Diabetes care (2019)
In obese humans with microvascular insulin resistance, GLP-1's vasodilatory actions are preserved in both skeletal and cardiac muscle microvasculature, which may contribute to improving metabolic insulin responses and cardiovascular outcomes.